Heart, Lung and Circulation
Volume 17, Issue 6 , Pages 488-496, December 2008

Eosinophilia and Coronary Artery Vasospasm

  • Chi Wing Wong, MBChB
  • ,
  • Sushil Luis, MBBS
  • ,
  • Irene Zeng, MSc
  • ,
  • Ralph A.H. Stewart, MD, FCSANZ

      Affiliations

    • Corresponding Author InformationCorresponding author at: Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92 024, Auckland 1030, New Zealand. Tel.: +64 9 307 4949x23668; fax: +64 9 307 4949x23699.

Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand

Received 17 March 2008; received in revised form 17 June 2008; accepted 17 June 2008.

Objective

To describe the clinical features, natural history and response to treatment of coronary vasospasm associated with eosinophilia.

Methods

Two patients with eosinophilia who had recurrent acute coronary events due to multi-vessel coronary artery spasm are described. The clinical presentation and outcomes of these 2 patients and 17 additional cases of eosinophilia and coronary artery vasospasm identified on a systematic literature review are presented.

Results

Patients were usually admitted because of repeated episodes of angina at rest and raised plasma markers of myocyte necrosis. Dynamic ST elevation was observed in 15 (83%) patients. Coronary angiography was performed in all patients. Spontaneous (n=7) or provoked (n=8) coronary artery spasm, which was usually multi-focal, was observed in 15 (83%) patients. Symptoms often continued despite high dose vasodilators but responded well to prednisone. Recurrent coronary events were frequent, and included sudden death (n=4), resuscitated cardiac arrest (n=2), myocardial infarction (n=10) and unstable angina (n=11). Recurrent events were more frequent when not taking compared to when taking prednisone (4.2 versus 0.4 events/year, p=0.002, hazard ratio 11, 95% confidence interval 2.4–50).

Conclusion

Published case reports suggest that coronary vasospasm associated with eosinophilia responds poorly to conventional vasodilator treatment and the risk of recurrent coronary events is high. Most patients respond to treatment which suppresses the eosinophilia.

Keywords: Eosinophilia, Coronary arteritis, Coronary artery vasospasm

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1443-9506(08)00795-6

doi:10.1016/j.hlc.2008.06.003

Heart, Lung and Circulation
Volume 17, Issue 6 , Pages 488-496, December 2008